Given that we demonstrated that RGMB specifically supports the suppressive activity of sCTLA-4, we next investigated to what extent the amount of sCTLA-4 affected the negative correlations observed between RGMB expression and CTL activity in various cancer tissues. Here, RGMB is linked to cancer.